Introduction
============

Human papillomavirus (HPV) is one of the most common sexually transmitted infections.[@b1-ijwh-3-313],[@b2-ijwh-3-313] Over 50% of sexually active women are exposed to at least one HPV type during their lifetime.[@b2-ijwh-3-313] HPV infection occurs in women of all age groups and the highest rates of HPV infection are seen in women 20--24 years old.[@b3-ijwh-3-313] Most genital HPV infections are asymptomatic, transient, and resolve spontaneously without causing any disease. Genital HPV types have been classified as either high risk (mainly types 16 and 18) or low risk (mainly types 6 and 11), reflecting their potential risk of causing malignant lesions. Persistent infection of the cervix uteri with specific high-risk types of HPV is a prerequisite for the development of cervical intraepithelial neoplasia and cervical cancer.[@b4-ijwh-3-313] HPV types 16 and 18 cause approximately 70% of cervical cancers.

Cancer of the cervix uteri is the second most common cancer in women and is the most common gynecologic malignancy worldwide.[@b5-ijwh-3-313] There were about 530,232 new cases in 2008 alone, and 85.5% of these occurred in developing countries.[@b5-ijwh-3-313] Cervical cancer is a major public health problem and it is the leading cause of cancer-related deaths among women in developing countries.[@b6-ijwh-3-313] It is hoped that the available HPV vaccines will markedly reduce the burden of cervical cancer and other HPV-related diseases in developing countries.

There are two types of HPV vaccine that have received regulatory approval for use in cervical cancer prevention programs worldwide. These vaccines are prepared with recombinant technology, using purified L1 structural proteins that self-assemble to form HPV type-specific empty shells or virus-like particles (VLPs). There is a bivalent HPV-16/18 VLP vaccine and a quadrivalent HPV-6/11/16/18 VLP vaccine. The vaccines are best administered prior to exposure to the virus, ideally during preadolescence (ie, 9--13 years of age).[@b7-ijwh-3-313]

Several studies, mostly from developed countries, have shown that the knowledge of HPV infection and vaccines and the acceptability of these vaccines among health care providers and the general public vary from low to high.[@b8-ijwh-3-313]--[@b17-ijwh-3-313] Nurses in developing countries play an important role in immunization programs, particularly those for vaccine-preventable childhood diseases. Nurses administer these vaccines and provide health education to the public. Therefore, the awareness and knowledge of HPV infection and the attitude toward HPV vaccines among nurses will greatly influence the success of an immunization program against cervical cancer. The aim of this study was to assess awareness and knowledge of HPV infection and vaccines and to assess attitude toward these vaccines among female nurses at Lagos University Teaching Hospital, Lagos, Nigeria.

Materials and methods
=====================

This prospective, cross-sectional, descriptive study was performed in the outpatient clinics, wards, theater, and the Accident and Emergency Unit of Lagos University Teaching Hospital, from January 21, 2008, to February 15, 2008. There were 415 female nurses in employment at the time of the study. The hospital is a 750-bed tertiary health care facility, which serves as a referral center for Lagos and its environs (Lagos has a population of about 15 million people).

The sample size was calculated using a formula for finite population. Assuming that 50% of the female nurses had sufficient knowledge of genital HPV infection, a minimum sample of 215 female nurses was calculated with 95% confidence and 5% reliability. The entire population of female nurses in the hospital was selected for the study. The questionnaire was delivered by hand during working hours and was collected after completion. The objectives of the study were explained to the nurses and their verbal consent was obtained before they were given a pretested, structured, anonymous, self-administered, 19-item questionnaire with both closed and open-ended questions. The questions sought information on sociodemographic characteristics, on awareness and knowledge of cervical cancer, HPV infections, and HPV vaccines, and on acceptance of these vaccines.

Data entry and analysis was performed using Epi Info™ (v 3.2.2; Centers for Disease Control and Prevention, Atlanta, GA) statistical software. Descriptive statistics were generated and data presented as a mean (standard deviation) or median (range) for continuous variables and as a percentage for categorical variables. Comparisons of categorical responses were evaluated using χ^2^-test or Fisher's exact test. A *P*-value of \<0.05 was considered to be statistically significant. Ethical approval was obtained from the Health Research Ethics Committee of Lagos University Teaching Hospital.

Results
=======

Sociodemographic characteristics
--------------------------------

Two hundred and thirty questionnaires were distributed and 178 female nurses completed and returned their questionnaires. The response rate was 75.7% and the data were complete for all 178 respondents. Sociodemographic characteristics of the respondents are outlined in [Table 1](#t1-ijwh-3-313){ref-type="table"}. The mean age was 37.1 ± 3.1 years. One hundred and sixteen (65.2%) of the respondents were married, 56 (31.5%) were single, three (1.7%) were separated/divorced, and three (1.7%) were widowed. One hundred and sixty-five (92.7%) were Christians and 13 (7.3%) were Muslims. Most (38.8%) respondents were staff nurse midwives.

Awareness and knowledge of HPV infection and vaccines
-----------------------------------------------------

One hundred and seventy-seven of the nurses (99.4%) had heard of cervical cancer and 151 (84.8%) had heard of HPV infection (see [Table 2](#t2-ijwh-3-313){ref-type="table"}). The majority (70.1%) of them were aware of the association between cervical cancer and HPV infection. Most (72.9%) of the nurses who had heard of cervical cancer knew it could be prevented by Pap smear, while only 13% of them knew it could be prevented through vaccination.

About 90% of the nurses who had heard of HPV infection knew that it could be transmitted through sexual intercourse, while only eleven (7.3%) knew it could be transmitted by skin-to-skin contact. Less than half of the respondents who had heard of genital HPV infection knew that it could be prevented by vaccination (31.8%) and condom use (33.1%).

Most (74.7%) of the respondents had never heard of the HPV vaccines. Among the 45 nurses who had heard of the vaccines, only twelve (26.7%) knew they were for the prevention of cervical cancer, while 30 (66.7%) respondents thought they were for the prevention of HPV infection.

HPV vaccine acceptability
-------------------------

As [Table 2](#t2-ijwh-3-313){ref-type="table"} shows, 125 (70.2%) of the nurses stated they would want to be vaccinated, while 53 (29.8%) were unwilling to be vaccinated; the main reason given for unwillingness was insufficient knowledge about the HPV vaccines.

The majority (67.4%) of respondents supported vaccination of preadolescent girls, while 58 (32.6%) did not. The reasons given for not recommending HPV vaccination for preadolescent girls included (1) they are too young; (2) they are not yet sexually active; (3) they are not at risk for HPV infection; (4) vaccination will encourage premarital sex; and (5) the respondent had insufficient knowledge about the vaccines and its complications. Almost all the participants (99.4%) expressed a desire to have more information on HPV vaccines.

The awareness of HPV infection, cervical cancer, and the vaccines had no significant association with the willingness to be vaccinated or the intention to recommend the vaccine for preadolescent girls. The nurses who were willing to be vaccinated were more likely to recommend the vaccines for preadolescent girls (*P* \< 0.001) ([Table 3](#t3-ijwh-3-313){ref-type="table"}).

Discussion
==========

The knowledge of HPV infection and vaccines among nurses in this study was relatively low. Despite the fact that many were aware of cervical cancer and HPV infection, a relatively low proportion (70.1%) knew about the association between HPV infection and cervical cancer. In similar studies in Greece, New Zealand and Thailand the proportions of nurses who knew about this association were 78.5%, 71%, and 81.8% respectively.[@b18-ijwh-3-313]--[@b20-ijwh-3-313]

Several studies have shown that knowledge of HPV infection is high in countries with existing national HPV education programs. These programs have led to an improved awareness and knowledge of HPV infection and related diseases among health care providers and the general public.

In this Nigerian study, only a quarter of the nurses who had heard about the vaccines knew they were for the prevention of cervical cancer. This is relatively low compared with 39.1% in the Thailand.[@b20-ijwh-3-313] The poor knowledge of the HPV vaccines among the nurses in this Nigerian study may be due to the lack of HPV and cervical cancer education programs in Nigeria. The vaccines were launched in Nigeria in September 2008, long after the study was conducted.

Over two-thirds of the female nurses were willing to be vaccinated. This is a similar result to that obtained from nurses in the Thai study.[@b20-ijwh-3-313] Most (67.4%) of the nurses were also willing to recommend the HPV vaccines for preadolescent girls. This finding is consistent with what has been reported in other recent studies.[@b9-ijwh-3-313],[@b10-ijwh-3-313],[@b15-ijwh-3-313],[@b17-ijwh-3-313],[@b21-ijwh-3-313] These studies found there was a high level of public interest in HPV vaccination, despite an overall low knowledge about HPV infection and related diseases. Studies have also shown that the main predictors of providers' intention to recommend HPV vaccination are endorsement by professional organizations and provider knowledge of and attitude toward HPV vaccination.[@b19-ijwh-3-313],[@b21-ijwh-3-313],[@b22-ijwh-3-313] Likewise, the authors found that the nurses who were willing to be vaccinated were more likely to recommend the vaccine for preadolescent girls.

The main reason given by many of the nurses for not accepting the HPV vaccines or recommending them for preadolescent girls was insufficient information about the efficacy and safety of the vaccines. Another reason given was that preadolescent girls were not at risk for HPV infection or cervical cancer and therefore had no need for the vaccines. Other studies have also identified these factors as barriers to effective HPV immunization.[@b10-ijwh-3-313],[@b23-ijwh-3-313]--[@b25-ijwh-3-313] Almost all of the nurses expressed their desire to receive more information about the vaccines.

The potential limitations of this study include the relatively small sample size and the fact that, as a self-administered

Conclusion
==========

The knowledge of the HPV infection and vaccines among female nurses in this study was poor. Despite their poor knowledge, most of the nurses were willing to be vaccinated and would recommend the vaccines for preadolescent girls. The main reason given overall for not recommending the vaccines was lack of information. There is an urgent need to bridge this information gap through a well-designed HPV education program integrated into a national cervical cancer prevention and control program.
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###### 

Sociodemographic characteristics (n = 178)

  Age distribution (years)   Respondents (n)   Respondents (%)
  -------------------------- ----------------- -----------------
  20--29                     56                31.4
  30--39                     50                28.1
  40--49                     50                28.1
  ≥50                        22                12.4
  **Marital status**                           
  Single                     56                31.5
  Married                    116               65.2
  Divorced/separated         3                 1.7
  Widowed                    3                 1.7
  **Religion**                                 
  Christian                  165               92.7
  Muslim                     13                7.3
  **Tribe**                                    
  Yoruba                     96                53.9
  Ibo                        42                23.6
  Other                      40                22.5
  **Position/Designation**                     
  CNO                        25                14.0
  Assistant CNO              15                8.4
  Principal NO               33                18.5
  Senior NO                  14                7.9
  NO                         22                12.4
  Staff nurse midwife        69                38.8

**Abbreviations:** CNO, chief nursing officer; NO, nursing officer; n, number.

###### 

Awareness and knowledge of cervical cancer, human papillomavirus (HPV) infection, and HPV vaccines, and acceptability of these vaccines (n = 178)

  Question                                                                     Yes (n)                Yes (%)
  ---------------------------------------------------------------------------- ---------------------- ---------
  Ever heard of cervical cancer?                                               177                    99.4
  Ever heard of HPV infection?                                                 151                    84.8
  Ever heard of HPV vaccine?                                                   45                     25.3
  Would you want to receive a vaccine that can prevent cervical cancer?        125                    70.2
  Would you support vaccination of preadolescent girls?                        120                    67.4
  **Knowledge of cervical cancer**[a](#tfn2-ijwh-3-313){ref-type="table-fn"}   **Correct response**   
                                                                               **(n)**                **(%)**
                                                                                                      
  Cervical cancer is the commonest gynecological cancer in Nigeria             171                    96.6
  Cervical cancer is caused by HPV infection                                   124                    70.1
  Cervical cancer is preventable                                               164                    92.7
  How can cervical cancer be prevented?                                                               
   Pap smear                                                                   129                    72.9
   Vaccination                                                                 23                     13.0
  **Knowledge of HPV infection**[b](#tfn3-ijwh-3-313){ref-type="table-fn"}                            
  HPV infection is associated with genital warts                               117                    77.5
  How is HPV infection transmitted?                                                                   
   Sexual contact                                                              135                    89.4
   Skin-to-skin contact                                                        11                     7.3
  How can genital HPV infection be prevented?                                                         
   Sexual abstinence                                                           63                     41.7
   Condom use                                                                  50                     33.1
   Vaccination                                                                 48                     31.8
  **Knowledge of HPV vaccine**[c](#tfn4-ijwh-3-313){ref-type="table-fn"}                              
  What is the HPV vaccine used for?                                                                   
   Prevention of HPV infection                                                 30                     66.7
   Prevention of cervical cancer                                               12                     26.7
   Prevention of genital warts                                                 5                      11.1
  Age group eligible for the HPV vaccine                                                              
   9--26 years                                                                 11                     24.4

**Notes:** Only respondents who had heard of cervical cancer;

only respondents who had heard of HPV infection;

only respondents who had heard of HPV vaccine.

**Abbreviation:** n, number.

###### 

Relationship between awareness of human papillomavirus (HPV) infection, cervical cancer, and HPV vaccines and acceptance of these vaccines

  Awareness                        Willingness to receive HPV vaccine                                                                
  -------------------------------- --------------------------------------------------------------- ----------------- --------------- --------------------------------------------------
  Ever heard of HPV infection?                                                                                                       
   Yes                             104                                                             47                0.87            0.351
   No                              21                                                              6                                 
  Ever heard of cervical cancer?                                                                                                     
   Yes                             124                                                             53                NA              1.000[\*](#tfn6-ijwh-3-313){ref-type="table-fn"}
   No                              1                                                               0                                 
  Ever heard of HPV vaccine?                                                                                                         
   Yes                             32                                                              13                0.02            0.880
   No                              93                                                              40                                
                                   **Intention to recommend HPV vaccine to preadolescent girls**                                     
                                   **Yes (n = 120)**                                               **No (n = 58)**   **χ^2^-Test**   ***P*-value**
                                                                                                                                     
  Ever heard of HPV infection?                                                                                                       
   Yes                             104                                                             47                0.96            0.326
   No                              16                                                              11                                
  Ever heard of cervical cancer?                                                                                                     
   Yes                             119                                                             58                NA              1.000[\*](#tfn6-ijwh-3-313){ref-type="table-fn"}
   No                              1                                                               0                                 
  Ever heard of HPV vaccine?                                                                                                         
   Yes                             31                                                              14                0.06            0.807
   No                              89                                                              44                                
  Willing to receive vaccine?                                                                                                        
   Yes                             97                                                              28                19.82           \<0.001
   No                              23                                                              30                                

**Note:** Fisher's exact test.

**Abbreviations:** NA, not available; n, number. questionnaire was used to collect data, it is possible that some respondents might have given incorrect information.
